(Updated - April 15, 2025 7:18 AM EDT)

Guggenheim analyst Etzer Darout raised the price target on Verve Therapeutics ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE